What companies are GMAB's competitors?

Genmab A/S (GMAB)'s closest competitors are the companies in the same industry classification, listed in the Peers to Research table on this page. Click any peer ticker to open its full analysis.

How does GMAB compare to its peers?

The peer comparison table on this page shows Genmab A/S (GMAB) alongside each peer with price, market cap, and key valuation / dividend metrics aligned side-by-side. Use it to spot relative outliers within the same business model.

What sector does GMAB operate in?

Genmab A/S (GMAB) operates in the Biotechnology industry within the Healthcare sector. Peers are drawn from this classification — companies with similar revenue mix, cost structure, and customer demand drivers.

GMAB

Genmab A/S

NASDAQ·Biotechnology · Healthcare

$28.85$0.49+1.71%

After hours·$28.85+0.00%

Market cap$17.71B·Market closed·Jul 22 8:00 PM UTC

Frequently Asked Questions About GMAB

What companies are GMAB's competitors?: Genmab A/S (GMAB)'s closest competitors are the companies in the same industry classification, listed in the Peers to Research table on this page. Click any peer ticker to open its full analysis.
How does GMAB compare to its peers?: The peer comparison table on this page shows Genmab A/S (GMAB) alongside each peer with price, market cap, and key valuation / dividend metrics aligned side-by-side. Use it to spot relative outliers within the same business model.
What sector does GMAB operate in?: Genmab A/S (GMAB) operates in the Biotechnology industry within the Healthcare sector. Peers are drawn from this classification — companies with similar revenue mix, cost structure, and customer demand drivers.

GMAB

Genmab A/S

NASDAQ·Biotechnology · Healthcare

$28.85$0.49+1.71%

After hours·$28.85+0.00%

Market cap$17.71B·Market closed·Jul 22 8:00 PM UTC

Peers


ILMN	Illumina, Inc.	$190.87	$28.9B
RPRX	Royalty Pharma plc	$58.72	$25.3B
ROIV	Roivant Sciences Ltd.	$34.91	$25.1B
DGX	Quest Diagnostics Incorporated	$209.83	$23.2B
INCY	Incyte Corporation	$115.79	$23.1B
UTHR	United Therapeutics Corporation	$527.07	$22.4B
ZBH	Zimmer Biomet Holdings, Inc.	$88.68	$17.2B
THC	Tenet Healthcare Corporation	$195.35	$16.8B
EXEL	Exelixis, Inc.	$54.98	$13.8B
SMMT	Summit Therapeutics Inc.	$14.74	$11.4B

Frequently Asked Questions About GMAB

What companies are GMAB's competitors?: Genmab A/S (GMAB)'s closest competitors are the companies in the same industry classification, listed in the Peers to Research table on this page. Click any peer ticker to open its full analysis.
How does GMAB compare to its peers?: The peer comparison table on this page shows Genmab A/S (GMAB) alongside each peer with price, market cap, and key valuation / dividend metrics aligned side-by-side. Use it to spot relative outliers within the same business model.
What sector does GMAB operate in?: Genmab A/S (GMAB) operates in the Biotechnology industry within the Healthcare sector. Peers are drawn from this classification — companies with similar revenue mix, cost structure, and customer demand drivers.